Takeda Pharmaceutical Co's cash flow for dividends for the
three
months ended in Mar. 2026 was 円-8,787 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was 円-311,901 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
Takeda Pharmaceutical Co's quarterly payment of dividends
increased
from Sep. 2025 (円-8,787 Mil) to Dec. 2025 (円-149,032 Mil) but then
declined
from Dec. 2025 (円-149,032 Mil) to Mar. 2026 (円-8,787 Mil).
Takeda Pharmaceutical Co's annual payment of dividends
increased
from Mar. 2024 (円-287,188 Mil) to Mar. 2025 (円-302,498 Mil) and
increased
from Mar. 2025 (円-302,498 Mil) to Mar. 2026 (円-311,901 Mil).
Takeda Pharmaceutical Co Cash Flow for Dividends Related Terms
Takeda Pharmaceutical Co Cash Flow for Dividends Historical Data
* Premium members only.
The historical data trend for Takeda Pharmaceutical Co's Cash Flow for Dividends can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takeda Pharmaceutical Co Cash Flow for Dividends Chart
Takeda Pharmaceutical Co Cash Flow for Dividends Calculation
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-311,901 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow for Dividends of 円-311,901 Mil mean?
Takeda Pharmaceutical Co (TSE:4502) has a Cash Flow for Dividends of 円-311,901 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Takeda Pharmaceutical Co and its competitors.
Is Takeda Pharmaceutical Co's Cash Flow for Dividends too high?
Takeda Pharmaceutical Co's current Cash Flow for Dividends is 円-311,901 Mil. Overall, Takeda Pharmaceutical Co has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Cash Flow for Dividends compare to ZTS and UTHR?
Takeda Pharmaceutical Co's Cash Flow for Dividends of 円-311,901 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Takeda Pharmaceutical Co and its competitors. Takeda Pharmaceutical Co's current Cash Flow for Dividends is 円-311,901 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (TSE:4502) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,531.71, compared to a current price of 円5,087.00 — trading 12.3% above its estimated fair value. The current Cash Flow for Dividends is 円-311,901 Mil. Takeda Pharmaceutical Co's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Takeda Pharmaceutical Co (TSE:4502), the current Cash Flow for Dividends is 円-311,901 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Takeda Pharmaceutical Co (TSE:4502) Overvalued in 2026?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円5,087.00 is trading 12.3% above its estimated GF Value™ of 円4,531.71.
GuruFocus considers Takeda Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for TSE:4502:
Cash Flow for Dividends: 円-311,901 Mil
GF Value™: 円4,531.71 vs. price of 円5,087.00 (12.3% above fair value)
No single metric tells the full story. See the TSE:4502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
68GF Score
Get the complete analysis for TSE:4502
Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4502 has been successfully added to your 
